Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Short Title: LUNGMAP

Enrollment Status: Recruiting

NCT #: NCT03851445

Specialty Area: Oncology

Condition Studied: Non-Small Cell Lung Cancer (NSCLC)

Age Groups: Adult; Older Adult

Phase: Not Applicable

Study Information

Summary / Purpose

To test a new way of screening people with lung cancer by using genetic information from their tumor to match them to the most promising treatment study.

Study Type: Observational

Accepts Healthy Volunteers: No

Who Can Participate

Eligibility Criteria:

Adults 18+ years of age
Diagnosed with Non-Small Cell Lung Cancer (NSCLC) that has already been treated
Willing to provide a tissue sample for genetic testing
Eligible for follow-up treatment based on test results

What's Involved

Participation in the study will include:

Providing a tissue sample for genetic testing
Placement to either a matched sub-study to test a new targeted treatment or a non-match sub-study with standard treatment options
No medications given during screening

Principal Investigator

Katharine Thomas, MD

Oncology

A Member of

(775) 982–2820

Renown Hematology/Oncology

View Provider

Additional Information

Location: Renown Health, Office of Clinical Research
Address:

1500 E 2nd St. Reno, NV 89502

General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org

Complete Study Details: https://clinicaltrials.gov/study/NCT03851445

Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.

Health & Wellness eNews